Investment Analysts’ Weekly Ratings Updates for CME Group (CME)

Several brokerages have updated their recommendations and price targets on shares of CME Group (NASDAQ: CME) in the last few weeks:

• 8/1/2026 – CME Group was downgraded by Wall Street Zen from “sell” to “strong sell”.
• 7/23/2026 – CME Group had its price target raised by Morgan Stanley from $324.00 to $330.00. They now have an “overweight” rating on the stock.
• 7/23/2026 – CME Group had its price target raised by Bank of America Corporation from $226.00 to $230.00. They now have an “underperform” rating on the stock.
• 7/23/2026 – CME Group had its price target raised by JPMorgan Chase & Co. from $249.00 to $250.00. They now have an “underweight” rating on the stock.
• 7/15/2026 – CME Group had its price target lowered by Piper Sandler from $329.00 to $295.00. They now have an “overweight” rating on the stock.
• 7/13/2026 – CME Group was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 7/12/2026 – CME Group was downgraded by Wall Street Zen from “hold” to “sell”.
• 7/10/2026 – CME Group had its price target lowered by Morgan Stanley from $353.00 to $324.00. They now have an “overweight” rating on the stock.
• 7/9/2026 – CME Group had its price target lowered by Barclays PLC from $316.00 to $270.00. They now have an “equal weight” rating on the stock.
• 7/6/2026 – CME Group had its price target lowered by UBS Group AG from $310.00 to $260.00. They now have a “buy” rating on the stock.
• 7/6/2026 – CME Group had its price target lowered by UBS Group AG from $310.00 to $260.00. They now have a “neutral” rating on the stock.
• 7/2/2026 – CME Group had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. They now have a $320.00 price target on the stock.
• 6/30/2026 – CME Group had its price target lowered by The Goldman Sachs Group, Inc. from $267.00 to $245.00. They now have a “sell” rating on the stock.
• 6/25/2026 – CME Group was downgraded by Weiss Ratings from “buy (b+)” to “buy (b)”.
• 6/22/2026 – CME Group had its price target lowered by TD Cowen from $323.00 to $273.00. They now have a “buy” rating on the stock.
• 6/18/2026 – CME Group was upgraded by Keefe, Bruyette & Woods from “market perform” to “outperform”. They now have a $305.00 price target on the stock.
• 6/17/2026 – CME Group was given a new $320.00 price target by Piper Sandler.
• 6/15/2026 – CME Group had its “overweight” rating reaffirmed by Piper Sandler. They now have a $329.00 price target on the stock.
• 6/15/2026 – CME Group had its “overweight” rating reaffirmed by UBS Group AG.
• 6/13/2026 – CME Group was upgraded by Wall Street Zen from “sell” to “hold”.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is currently 44.11%.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by company insiders.

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.